These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37286088)

  • 1. Truncation or proteolysis of α-synuclein in Parkinsonism.
    Suthar SK; Lee SY
    Ageing Res Rev; 2023 Sep; 90():101978. PubMed ID: 37286088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy.
    Sorrentino ZA; Hass E; Vijayaraghavan N; Gorion KM; Riffe CJ; Dhillon JS; Giasson BI
    Neurosci Lett; 2020 Jul; 732():135017. PubMed ID: 32371157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.
    Sorrentino ZA; Vijayaraghavan N; Gorion KM; Riffe CJ; Strang KH; Caldwell J; Giasson BI
    J Biol Chem; 2018 Dec; 293(49):18914-18932. PubMed ID: 30327435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of truncation on prion-like properties of α-synuclein.
    Terada M; Suzuki G; Nonaka T; Kametani F; Tamaoka A; Hasegawa M
    J Biol Chem; 2018 Sep; 293(36):13910-13920. PubMed ID: 30030380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathies.
    Hass EW; Sorrentino ZA; Xia Y; Lloyd GM; Trojanowski JQ; Prokop S; Giasson BI
    Acta Neuropathol Commun; 2021 Aug; 9(1):146. PubMed ID: 34454615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
    Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathology and molecular diagnosis of Synucleinopathies.
    Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
    Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies.
    Graves NJ; Gambin Y; Sierecki E
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders.
    Altay MF; Liu AKL; Holton JL; Parkkinen L; Lashuel HA
    Acta Neuropathol Commun; 2022 Nov; 10(1):163. PubMed ID: 36371251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy.
    Ayers JI; Lee J; Monteiro O; Woerman AL; Lazar AA; Condello C; Paras NA; Prusiner SB
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35115402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging role of α-synuclein truncation in aggregation and disease.
    Sorrentino ZA; Giasson BI
    J Biol Chem; 2020 Jul; 295(30):10224-10244. PubMed ID: 32424039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of α-Synuclein Seeding-Dependent Aggregation by ssDNA Aptamers Specific to C-Terminally Truncated α-Synuclein Fibrils.
    Hmila I; Sudhakaran IP; Ghanem SS; Vaikath NN; Poggiolini I; Abdesselem H; El-Agnaf OMA
    ACS Chem Neurosci; 2022 Dec; 13(23):3330-3341. PubMed ID: 36348612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis.
    Lloyd GM; Long B; Quintin S; Sorrentino ZA; Gorion KM; Bell BM; Carrillo D; Sullivan P; Borchelt D; Giasson BI
    Acta Neuropathol Commun; 2023 Jul; 11(1):119. PubMed ID: 37482615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
    J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
    Poggiolini I; Erskine D; Vaikath NN; Ponraj J; Mansour S; Morris CM; El-Agnaf OMA
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34072869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryo-EM structure of amyloid fibril formed by α-synuclein hereditary A53E mutation reveals a distinct protofilament interface.
    Sun C; Zhou K; DePaola P; Shin WS; Hillyer T; Sawaya MR; Zhu R; Peng C; Zhou ZH; Jiang L
    J Biol Chem; 2023 Apr; 299(4):104566. PubMed ID: 36871760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation.
    Kim YM; Jang WH; Quezado MM; Oh Y; Chung KC; Junn E; Mouradian MM
    J Neurol Sci; 2011 Aug; 307(1-2):157-61. PubMed ID: 21641618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.
    Hartlage-Rübsamen M; Bluhm A; Moceri S; Machner L; Köppen J; Schenk M; Hilbrich I; Holzer M; Weidenfeller M; Richter F; Coras R; Serrano GE; Beach TG; Schilling S; von Hörsten S; Xiang W; Schulze A; Roßner S
    Acta Neuropathol; 2021 Sep; 142(3):399-421. PubMed ID: 34309760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.
    McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC
    J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations.
    de Boni L; Watson AH; Zaccagnini L; Wallis A; Zhelcheska K; Kim N; Sanderson J; Jiang H; Martin E; Cantlon A; Rovere M; Liu L; Sylvester M; Lashley T; Dettmer U; Jaunmuktane Z; Bartels T
    Acta Neuropathol; 2022 Apr; 143(4):453-469. PubMed ID: 35141810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.